This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
Accession | PRJNA771650; GEO: GSE185983 |
Type | Umbrella project |
Publications | Togami K et al., "Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis.", Cancer Discov, 2022 Feb;12(2):522-541 |
Submission | Registration date: 15-Oct-2021 Dana-Farber Cancer Institute |
Relevance | Superseries |
Project Data:
Resource Name | Number of Links |
---|
Sequence data |
SRA Experiments | 33 |
Publications |
PubMed | 1 |
PMC | 1 |
Other datasets |
BioSample | 33 |
GEO DataSets | 3 |
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis encompasses the following 2 sub-projects:
Project Type | Number of Projects |
Transcriptome or Gene expression | 2 |
BioProject accession | Organism | Title |
---|
PRJNA771654 | Homo sapiens | Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis [cell line] (Dana-Farber Cancer Institute) | PRJNA765578 | Homo sapiens | Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis [patients] (Dana-Farber Cancer Institute) |
|